| 来源类型 | Working Paper
|
| 规范类型 | 报告
|
| DOI | 10.3386/w12968
|
| 来源ID | Working Paper 12968
|
| Strategic Responses to Parallel Trade |
| Margaret K. Kyle
|
| 发表日期 | 2007-03-14
|
| 出版年 | 2007
|
| 语种 | 英语
|
| 摘要 | This paper examines how pharmaceutical firms have responded to changes in intellectual property rights and trade barriers that legalized "parallel imports" within the European Union. The threat of arbitrage by parallel traders reduces the ability of firms to price discriminate across countries. Due to regulations on price and antitrust law on rationing supply, pharmaceutical firms may rely on non-price responses. Such responses include differentiation of products across countries and selective "culling" of product lines to reduce arbitrage opportunities, as well as raising arbitrageurs' costs through choice of packaging. Using a dataset of drug prices and sales from 1993-2004 covering 30 countries, I find evidence that the behavior of pharmaceutical firms in the EU with respect to their product portfolios is consistent with attempts to reduce parallel trade. This may at least partially explain why parallel trade has not yet resulted in significant price convergence across EU countries. Accounting for non-price strategic responses may therefore be important in assessing the welfare effects of parallel imports. |
| 主题 | Microeconomics
; Households and Firms
; Industrial Organization
; Market Structure and Firm Performance
|
| URL | https://www.nber.org/papers/w12968
|
| 来源智库 | National Bureau of Economic Research (United States)
|
| 引用统计 |
|
| 资源类型 | 智库出版物
|
| 条目标识符 | http://119.78.100.153/handle/2XGU8XDN/570634
|
推荐引用方式
GB/T 7714 |
Margaret K. Kyle. Strategic Responses to Parallel Trade. 2007.
|
|
文件名：
|
w12968.pdf
|
|
格式：
|
Adobe PDF
|
此文件暂不支持浏览
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
